Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
29(48%)
Results Posted
19%(3 trials)

Phase Distribution

Ph early_phase_1
3
5%
Ph phase_2
1
2%
Ph phase_3
1
2%
Ph not_applicable
54
89%
Ph phase_1
2
3%

Phase Distribution

5

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution61 total trials
Early Phase 1First-in-human
3(4.9%)
Phase 1Safety & dosage
2(3.3%)
Phase 2Efficacy & side effects
1(1.6%)
Phase 3Large-scale testing
1(1.6%)
N/ANon-phased studies
54(88.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

29

trials recruiting

Total Trials

61

all time

Status Distribution
Active(42)
Completed(16)
Other(3)

Detailed Status

Recruiting27
Completed16
Not yet recruiting8
Enrolling by invitation5
unknown3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
61
Active
29
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (4.9%)
Phase 12 (3.3%)
Phase 21 (1.6%)
Phase 31 (1.6%)
N/A54 (88.5%)

Trials by Status

not_yet_recruiting813%
active_not_recruiting23%
completed1626%
enrolling_by_invitation58%
unknown35%
recruiting2744%

Recent Activity

Clinical Trials (61)

Showing 20 of 61 trialsScroll for more
NCT07619989Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

Recruiting
NCT07730762Not Applicable

A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During Pregnancy

Active Not Recruiting
NCT07719868Not Applicable

TaVNS for Capsaicin-Induced Pain

Not Yet Recruiting
NCT06953388Early Phase 1

Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD

Not Yet Recruiting
NCT07689981Not Applicable

The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder

Not Yet Recruiting
NCT07557706Phase 1

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

Recruiting
NCT07425652Not Applicable

Physiotherapy Methods for Fibromyalgia

Recruiting
NCT07630597Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention

Recruiting
NCT07300774Not Applicable

Vagus Nerve Stimulation in Premature Ejaculation

Completed
NCT07549243Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Enrolling By Invitation
NCT07078058Not Applicable

Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy

Completed
NCT07593365Not Applicable

Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain

Not Yet Recruiting
NCT07543302Not Applicable

Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?

Enrolling By Invitation
NCT07548723Not Applicable

taVNS During Multi-site HRV Measurement: Reliability & Agreement Study

Enrolling By Invitation
NCT07526415Not Applicable

Effect of Recording Duration on Heart Rate Variability During taVNS

Not Yet Recruiting
NCT05588063Not Applicable

taVNS for FRNS in Children

Recruiting
NCT07524491Not Applicable

taVNS During Exercise and Recovery in Chronic Spinal Cord Injury

Completed
NCT06793800Not Applicable

Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients

Recruiting
NCT07284732Not Applicable

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Patients With Disorders of Consciousness

Recruiting
NCT06258590Not Applicable

taVNS for Anxiety in ASD

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
61